To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria

NCT02497612 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
377
Enrollment
INDUSTRY
Sponsor class

Stopped All treatment arms met the futility criteria for efficacy during the pre-planned interim analysis, therefore the study was stopped.

Conditions

Interventions

Sponsor

Sanofi

Collaborators